Jo Ann Horowitz

Adenovirus-Mediated Wild-Type p53 Gene Transfer in Patients Receiving Chemotherapy for Advanced Non–Small-Cell Lung Cancer: Results of a Multicenter Phase II Study

Martin Schüler, Richard Herrmann, Jacques De Grève et al. · Journal of Clinical Oncology · 2001 · 210 citations

Medicine, Oncology, Pharmacology +13

Targeting, dosimetry, and radioimmunotherapy of B-cell lymphomas with iodine-131-labeled LL2 monoclonal antibody.

David M. Goldenberg, Jo Ann Horowitz, Robert M. Sharkey et al. · Journal of Clinical Oncology · 1991 · 202 citations

Medicine, Nuclear Medicine, Oncology +17

A phase I/II trial of rAd/p53 (SCH 58500) gene replacement in recurrent ovarian cancer

Richard E. Buller, Ingo B. Runnebaum, Beth Y. Karlan et al. · Cancer Gene Therapy · 2002 · 165 citations

Medicine, Molecular Genetics, Oncology +16

A Phase I Study of Adenovirus-Mediated Wild-Type <i>p53</i> Gene Transfer in Patients with Advanced Non-Small Cell Lung Cancer

Martin Schüler, Christoph Rochlitz, Jo Ann Horowitz et al. · Human Gene Therapy · 1998 · 164 citations

Life Sciences, Molecular Biology, Oncology +17

Phase I and Pharmacologic Trial of Cytosine Arabinoside with the Selective Checkpoint 1 Inhibitor Sch 900776 in Refractory Acute Leukemias

Judith E. Karp, B M Thomas, Jacqueline M. Greer et al. · Clinical Cancer Research · 2012 · 117 citations · Full text

Medicine, Oncology, Pharmacology +17